CBT is Effective for Tourette’s Syndrome

researchlogo72x65bl-new.jpgA new study is the first to show that CBT (cognitive behavioral therapy) is effective in patients with Tourette’s syndrome and tic disorders, regardless of their medication status or symptom severity. 76 adult participants, all of whom had been diagnosed with the aforementioned conditions, were divided into two groups; those who were prescribed medication and those who were not. All of the participants underwent four months of individualized, manual-based CBT. Before and after receiving CBT, measures were taken to assess depression, anxiety, obsessive-compulsive symptoms, and planning style. Also, the Tourette Syndrome Global Scale was employed to assess various factors, including severity and treatment outcome.

 The results demonstrated that both groups—medicated and unmedicated—greatly improved from the CBT. The unmedicated group improved in terms of anxiety, while both groups’ depressive symptoms decreased.

CBT is Effective for Irritable Bowel Syndrome

researchlogo72x65bl.jpgA recent study posted in Clinical Gastroenterology and Hepatology, a journal publishing clinical articles on all aspects of the digestive system, shows evidence that cognitive behavioral therapy (CBT) is an effective treatment for irritable bowl syndrome (IBS).

The study included 71 participants, with moderately severe IBS symptoms, who were randomly assigned to one of two conditions; they either received 10 weekly 1-hour sessions of CBT, or 4 1-hour sessions over 10 weeks.

Results showed that “rapid responders”, those who began to see improvements in their IBS symptoms within the first 4 weeks, had maintained the improvements at both immediate and 3-month check ups after treatment had ended. No difference was observed between the patients who received 4 sessions and those who received 10 sessions during the 10 weeks.

Lackner, J. M., Gudleski, G. D., Keefer, L., Powell, C., & Katz, L. A. (2010). Rapid response to    cognitive behavior therapy predicts treatment outcome in patients with irritable bowel syndrome, Clinical Gastroenterology and Hepatology, 8, 426-432.